When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão: 21 Mar 2025
Última atualização: 29 May 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • preocupação excessiva que dura há, pelo menos, 6 meses
  • ansiedade não limitada a outro transtorno mental
  • ansiedade não decorrente de medicamento ou substância
  • tensão muscular
  • perturbação do sono
  • fadiga
  • sono agitado
  • irritabilidade
  • baixa concentração

Outros fatores diagnósticos

  • cefaleia
  • sudorese
  • tontura
  • sintomas gastrointestinais
  • dores musculares
  • frequência cardíaca aumentada
  • dispneia
  • tremores
  • resposta de sobressalto exagerada
  • dor torácica

Fatores de risco

  • história familiar de ansiedade
  • estresse emocional ou físico
  • história de trauma emocional, físico ou sexual
  • outro transtorno de ansiedade
  • doença física crônica
  • sexo feminino

Investigações diagnósticas

Investigações a serem consideradas

  • testes da função tireoidiana
  • exame de urina para detecção de drogas
  • urina de 24 horas para catecolaminas, metanefrinas, normetanefrinas e creatinina
  • testes de função pulmonar
  • eletrocardiograma (ECG)

Algoritmo de tratamento

Colaboradores

Autores

Professor of Psychopharmacology

Department of Psychiatry

University of Oxford

Oxford

UK

Declarações

PJC declares that he has no competing interests.

Professor Philip John Cowen would like to gratefully acknowledge Dr Christopher Gale, Dr Richard P. Swinson, Dr Elizabeth Hoge, and Dr Phebe Tucker, previous contributors to this topic.

Declarações

CG is an author of the Royal Australian and New Zealand College of Psychiatrists clinical practice guideline on social phobia, panic disorder, and generalised anxiety disorder. Otago University has commercial and research relationships with multiple pharmaceutical companies. He is an author of a number of references cited in this topic. RPS has personally received royalties for articles published in UpToDate (Wolters Kluwer) and the Compendium of Therapeutic Choices, 2nd edition (Canadian Pharmacists Association). EH is an author of a number of references cited in this topic. PT has conducted research for GlaxoSmithKline, Bristol-Myers Squibb, Wyeth Pharmaceuticals, Astra-Zeneca, Cephalon, Inc., and Ortho-McNeil. She has also consulted for Forest Pharmaceuticals and received honoraria from Pfizer, Inc. and Forest Pharmaceuticals.

Revisores

Research Director

University of Alabama

School of Medicine Tuscaloosa Campus

College of Community Health Sciences

Tuscaloosa

AL

Declarações

LD declares that she has no competing interests.

Senior Clinical Lecturer

Division of Psychological Medicine and Clinical Neurosciences

Cardiff University

United Kingdom

Declarações

ADF declares that she has no competing interests.

Consultant in Paediatric Liaison Psychiatry

Royal Hospital for Children

Glasgow

United Kingdom

Declarações

EL declares that she has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal